1.Changes in Serum Dickkopf-1, RANK Ligand, Osteoprotegerin, and Bone Mineral Density after Allogeneic Hematopoietic Stem Cell Transplantation Treatment
Eunhee JANG ; Jeonghoon HA ; Ki-Hyun BAEK ; Moo Il KANG
Endocrinology and Metabolism 2021;36(6):1211-1218
Background:
Dickkopf-1 (DKK1) regulates bone formation by inhibiting canonical Wnt/β-catenin pathway signaling, and indirectly enhances osteoclastic activity by altering the expression ratio of receptor activator of nuclear factor-κB ligand (RANKL) relative to osteoprotegerin (OPG). However, it is difficult to explain continued bone loss after allogeneic stem cell transplantation (allo-SCT) in terms of changes in only RANKL and OPG. Few studies have evaluated changes in DKK1 after allo-SCT.
Methods:
We prospectively enrolled 36 patients with hematologic malignancies who were scheduled for allo-SCT treatment. Serum DKK1, OPG, and RANKL levels were measured before (baseline), and at 1, 4, 12, 24, and 48 weeks after allo-SCT treatment. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry before (baseline) and 24 and 48 weeks after allo-SCT treatment.
Results:
After allo-SCT treatment, the DKK1 level decreased rapidly, returned to baseline during the first 4 weeks, and remained elevated for 48 weeks (P<0.0001 for changes observed over time). The serum RANKL/OPG ratio peaked at 4 weeks and then declined (P<0.001 for changes observed over time). BMD decreased relative to the baseline at all timepoints during the study period, and the lumbar spine in female patients had the largest decline (–11.3%±1.6% relative to the baseline at 48 weeks, P<0.05).
Conclusion
Serum DKK1 levels rapidly decreased at 1 week and then continued to increase for 48 weeks; bone mass decreased for 48 weeks following engraftment in patients treated with allo-SCT, suggesting that DKK1-mediated inhibition of osteoblast differentiation plays a role in bone loss in patients undergoing allo-SCT.
2.Meta-analysis of the Efficacy and Safety of Grazoprevir and Elbasvir for the Treatment of Hepatitis C Virus Infection
Min Gu KANG ; Min Jung KANG ; Eunhee JI ; Bong Kyu YOO
Korean Journal of Clinical Pharmacy 2017;27(3):150-160
OBJECTIVE: Recently, a fixed combination of grazoprevir and elbasvir (GE) has been introduced to the arsenal of chemotherapeutics to fight against this virus. The study aimed to provide information on the efficacy and safety of GE for the treatment of HCV infection by performing a meta-analysis of literature data. METHODS: PubMed and EMBASE database searches were conducted. Among the literature retrieved, pivotal Phase III clinical studies were analyzed. Statistical analysis of the data was performed by RevMan. RESULTS: Four pivotal Phase III clinical studies compared the efficacy and safety of GE. When HCV patients were treated with GE for 12 weeks, the sustained virologic response, defined as the viral RNA level below the lower limit of quantification at 12 weeks after the cessation of therapy (SVR12), was 94.7%. The clinical advantage of GE involves its use by patients with cirrhosis and/or renal failure without dose adjustment. If the genotype (GT) of the causative virus was GT1a with NS5A polymorphism or GT4 with resistance to peginterferon/ribavirin, treatment with GE plus ribavirin for 16 weeks resulted in a better outcome compared to treatment with GE alone for 12 weeks. Adverse events reported during the four clinical studies were 71.09% in the GE arms and it was 76.61% in the non-GE arms, with the most frequent events being mild central nervous system symptoms. CONCLUSION: GE was generally safe and effective for the treatment of HCV infection. However, since HCV mutates very rapidly and becomes resistant to antiviral agents, long-term monitoring should be mandatory.
Antiviral Agents
;
Arm
;
Central Nervous System
;
Fibrosis
;
Genotype
;
Hepacivirus
;
Hepatitis C
;
Hepatitis
;
Humans
;
Renal Insufficiency
;
Ribavirin
;
RNA, Viral
3.Republic of Korea's Health Aid Governance: Perspectives from Partner Countries.
Allison Baer ALLEY ; Eunhee PARK ; Jong Koo LEE ; Minah KANG ; Juhwan OH
Journal of Korean Medical Science 2015;30(Suppl 2):S149-S154
The Republic of Korea (ROK) has a remarkable development history, including its status as the first country to transition from aid recipient to member of the Organization for Economic Cooperation and Development Development Assistance Committee (DAC). However, since becoming a donor country, the ROK has struggled to achieve internationally accepted agreements related to aid effectiveness and several evaluations have identified the ROK as being one of the weakest DAC member countries at providing good aid. A survey was conducted to assess partner countries' perceptions of the ROK's governance of health official development assistance (ODA). The survey was administered to government officials based in partner countries' Ministries of Health and therefore presents the unique perspective of ODA recipients. The survey questions focused on governance principles established in the internationally-accepted Paris Declaration on Aid Effectiveness. The total response rate was 13 responses out of 26 individuals who received the email request (50%). The survey results indicate that progress has been made since earlier international evaluations but the ROK has not overcome all areas of concern. This confirms that the ROK is continuing to develop its capacity as a good donor but has yet to achieve all governance-related targets. The results of this survey can be used to inform a future aid strategy.
Delivery of Health Care/*economics
;
Developing Countries/*economics
;
Financial Management/*economics
;
*Global Health
;
*International Cooperation
;
Republic of Korea
4.Bleeding after Taking Dual Antiplatelets and NSAID Concurrently.
Jeongmin SEO ; Joonghyuk CHOI ; Pyoungwoo SON ; Seungmin LEE ; Hyunwoo CHAE ; Geunhyung KANG ; Eunhee JI
Korean Journal of Clinical Pharmacy 2018;28(3):250-253
When stenting is applied to treat myocardial infarction, antiplatelet agents are administered to prevent thrombosis, which increases the risk of bleeding. Patients with myocardial infarction are also more likely to have osteoarthritis simultaneously, because both diseases occur frequently in elderly patients. Patients with osteoarthritis often use analgesics, especially nonsteroidal anti-inflammatory drugs (NSAIDs); hence, patients with both diseases use analgesics and antiplatelet agents simultaneously. The risk of bleeding increases with the use of antiplatelet agents and this is further increased when NSAIDs are added. We would like to report a case that reflects this situation. A 60-year-old man underwent stenting after ST-elevation myocardial infarction, and was treated with aspirin and clopidogrel. This patient also received a pelubiprofen prescription from another physician to treat osteoarthritis. After the patient took pelubiprofen twice, he found a bruise on his wrist and reported it to the pharmacist. It is unlikely that this is rare in community pharmacies, so pharmacists should pay careful attention to the concomitant administration of analgesics to patients receiving antiplatelet agents and should provide appropriate education to patients.
Aged
;
Analgesics
;
Anti-Inflammatory Agents, Non-Steroidal
;
Aspirin
;
Contusions
;
Education
;
Hemorrhage*
;
Humans
;
Middle Aged
;
Myocardial Infarction
;
Osteoarthritis
;
Pharmacies
;
Pharmacists
;
Platelet Aggregation Inhibitors
;
Prescriptions
;
Stents
;
Thrombosis
;
Wrist
5.CMT1B Patient with a Novel p.Arg98Leu MPZ Variant Mimicking Chronic Inflammatory Demyelinating Polyneuropathy on Electrodiagnostic Testing
Nathan JO ; Hee-Kyong KANG ; Hak-In LEE ; In-Young LEE ; Sooyoung KIM ; Seon-Young KIM ; Eunhee SOHN
Journal of the Korean Neurological Association 2022;40(3):251-255
Conduction block or temporal dispersion on motor nerve conduction studies (NCSs) are known as key features of chronic inflammatory demyelinating polyneuropathy. Some types of CharcotMarieTooth disease (CMT) have been also reported to show conduction block or temporal dispersion on NCS. We experienced a case who presented with slowly progressive motor weakness, sensory loss, foot deformity, and segmental demyelination on NCS. We confirmed her and her mother harboring CMT1B with a novel p.Arg98Leu MPZ variant.
6.Combined Endoscopic Third Ventriculostomy and Lumboperitoneal Shunt Surgery in an Elderly Patient With Complex Hydrocephalus: Mixture of Late-onset Obstructive and Communicating Hydrocephaluses
Sang-Youl YOON ; Kyunghun KANG ; Chaejin LEE ; Jeong-Hyun HWANG ; Myoung Hun HAHM ; Eunhee PARK ; Ki-Su PARK
Dementia and Neurocognitive Disorders 2023;22(1):46-48
7.Transesophageal echocardiographic guidance for percutaneous closure of aortic pseudoaneurysm using a type II Amplatzer vascular plug: a case report.
Hyo Jin KIM ; Sangmin Maria LEE ; Kiick SUNG ; I Seok KANG ; Jong Hwan LEE ; Jeong Jin MIN ; Eunhee KIM ; Jiyeon PARK ; Jin Hyoung PARK
Korean Journal of Anesthesiology 2016;69(4):400-405
Aortic pseudoaneurysm after cardiac surgery is a rare entity, but it is potentially fatal due to its clinical course along with higher morbidity and mortality rates. Instead of open surgical repair, percutaneous procedures have been introduced as other options for managing an aortic pseudoaneurysm. In this case report, we describe transesophageal echocardiography guidance for successful percutaneous closure of an aortic pseudoaneurysm located in the left ventricular outflow tract by using a type II Amplatzer vascular plug in a patient in whom open surgical repair was not recommended.
Aneurysm, False*
;
Echocardiography*
;
Echocardiography, Transesophageal
;
Humans
;
Mortality
;
Neoplasm Metastasis
;
Spinal Cord Compression
;
Spine
;
Thoracic Surgery
;
Vertebroplasty
8.Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis.
Yoo Li LIM ; Eunhee CHOI ; Yoon Ok JANG ; Youn Zoo CHO ; Yong Seok KANG ; Soon Koo BAIK ; Sang Ok KWON ; Moon Young KIM
Gut and Liver 2016;10(1):109-116
BACKGROUND/AIMS: Levels of serum apelin (s-apelin), an endogenous ligand for angiotensin-like receptor 1, have been shown to be related to hepatic fibrosis and hemodynamic abnormalities in preclinical studies. We investigated the clinical implications of s-apelin as a noninvasive prognostic biomarker for chronic liver disease (CLD). METHODS: From January 2009 to December 2012, 215 CLD patients were enrolled and underwent clinical data collection, hepatic venous pressure gradient (HVPG) measurement, and liver biopsy. s-apelin was detected with a human total apelin enzyme-linked immunosorbent assay kit. All patients were prospectively observed during the median follow-up period of 23.0±12.9 months for decompensation and mortality. RESULTS: A total of 42 patients (19.5%) died during the follow-up period. s-apelin was significantly correlated with measurements of liver stiffness (R2=0.263, p<0.001) and collagen proportional area (R2=0.213, p<0.001) measured from liver biopsy tissue and HVPG (R2=0.356, p<0.001). In a multivariate analysis using a Cox regression hazard model, s-apelin was a weakly significant predictor of decompensation (hazard ratio [HR], 1.002; p<0.001) and mortality (HR, 1.003; p<0.001). CONCLUSIONS: s-apelin showed a significant relationship with CLD severity. However, its significance as a noninvasive biomarker for disease severity and prognosis was weak.
Adult
;
Biomarkers/blood
;
Biopsy
;
Enzyme-Linked Immunosorbent Assay
;
Female
;
Follow-Up Studies
;
Humans
;
Hypertension, Portal/*blood/complications/mortality
;
Intercellular Signaling Peptides and Proteins/*blood
;
Liver/blood supply/pathology
;
Liver Cirrhosis/*blood/etiology/mortality/pathology
;
Male
;
Middle Aged
;
Portal Pressure
;
Prognosis
;
Proportional Hazards Models
;
Prospective Studies
9.Obstetrical Outcomes of Amniocentesis or Chorionic Villus Sampling in Dichorionic Twin Pregnancies
Mi Sun KIM ; Myoung Jin MOON ; Sukho KANG ; Sang Hee JUNG ; Sung Woon CHANG ; Hyo Jin KI ; Bohye KIM ; Eunhee AHN
Journal of Korean Medical Science 2019;34(18):e142-
BACKGROUND: Under certain situations, women with twin pregnancies may be counseled to undergo invasive prenatal diagnostic testing. Chorionic villus sampling and amniocentesis are the two generally performed invasive prenatal diagnostic tests. Studies comparing procedure-related fetal loss between first-trimester chorionic villus sampling and second-trimester amniocentesis in twin pregnancies are limited. This study aimed to evaluate the procedure-related fetal loss and the obstetrical outcomes of these two procedures, chorionic villus sampling and amniocentesis in twin pregnancies. METHODS: The data from dichorionic-diamniotic twin pregnancies on which first-trimester chorionic villus sampling (n = 54) or second-trimester amniocentesis (n = 170) was performed between December 2006 and January 2017 in a single center were retrospectively analyzed. The procedure-related fetal loss was classified as loss of one or all fetuses within 4 weeks of procedure, and overall fetal loss was classified as loss of one or all fetuses during the gestation. The groups were compared with respect to the procedure-related and obstetrical outcomes. RESULTS: The difference in proportion of procedure-related fetal loss rate (1.9% for chorionic villus sampling vs. 1.8% for amniocentesis; P = 1.000) and the overall fetal loss rate (7.4% for chorionic villus sampling vs. 4.7% for amniocentesis; P = 0.489) between the two groups was not significant. The mean gestational ages at delivery were not statistically significant. CONCLUSION: Both the overall fetal loss rate and the procedure-related fetal loss rate of chorionic villus sampling and amniocentesis in dichorionic twin pregnancies had no statistical significance. Both procedures can be safely used individually.
Amniocentesis
;
Chorion
;
Chorionic Villi Sampling
;
Chorionic Villi
;
Diagnostic Tests, Routine
;
Female
;
Fetus
;
Gestational Age
;
Humans
;
Pregnancy
;
Pregnancy, Twin
;
Retrospective Studies
;
Twins
10.Effect of Family Caregiving on Depression in the First 3 Months After Spinal Cord Injury
Min Gu KANG ; Chul Hyun KIM ; Eunhee PARK ; Jae Won HUH ; Won Jong YANG ; Tae Woo NAM ; Yu Sun MIN ; Tae Du JUNG
Annals of Rehabilitation Medicine 2018;42(1):130-136
OBJECTIVE: To investigate the effect of family caregiving on depression in the first 3 months after spinal cord injury (SCI). METHODS: A retrospective study was carried out on 76 patients diagnosed with an SCI from January 2013 to December 2016 at the Department of Physical Medicine and Rehabilitation of Kyungpook National University Hospital, Korea. Clinical characteristics including age, gender, level of injury, completeness of the injury, time since injury, caregiver information, etiology, and functional data were collected through a retrospective review of medical records. Depression was assessed using the Beck Depression Inventory (BDI). Patients with 14 or more points were classified as depressed and those with scores of 13 or less as non-depressed group. RESULTS: Of the 76 patients, 33 were in the depressed group with an average BDI of 21.27±6.17 and 43 patients included in the non-depressed group with an average BDI of 4.56±4.20. The BDI score of patients cared by unlicensed assistive personnel (UAP) was significantly higher than that of patients cared by their families (p=0.020). Univariate regression analysis showed that motor complete injury (p=0.027), UAP caregiving (p=0.022), and Ambulatory Motor Index (p=0.019) were associated with depression after SCI. Multivariate binary logistic regression analysis showed that motor completeness (p=0.002) and UAP caregiving (p=0.002) were independent risk factors. CONCLUSION: Compared with UAP, family caregivers lowered the prevalence of depression in the first 3 months after SCI.
Caregivers
;
Depression
;
Gyeongsangbuk-do
;
Humans
;
Korea
;
Logistic Models
;
Medical Records
;
Physical and Rehabilitation Medicine
;
Prevalence
;
Retrospective Studies
;
Risk Factors
;
Spinal Cord Injuries
;
Spinal Cord